D.E. Shaw & Co
EVH icon

D.E. Shaw & Co’s Evolent Health EVH Stock Holding History

D.E. Shaw & Co’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-61,500
Closed -$692K – 4391
2024
Q4 		$692K Hold
61,500
– – ﹤0.01% 3424
2024
Q3 		$1.74M Buy
+61,500
New +$1.59M ﹤0.01% 2810
2022
Q2 		– Sell
-20,000
Closed -$646K – 5446
2022
Q1 		$646K Hold
20,000
– – ﹤0.01% 4214
2021
Q4 		$553K Buy
+20,000
New +$574K ﹤0.01% 4345

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co's EVH Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Evolent Health (EVH) stake by 6% in Q2 2026, selling an estimated $1.25M and leaving 5,107,561 shares worth $27.7M. The position accounts for 0.01% of the portfolio, ranked #1086.

D.E. Shaw & Co first reported a position in EVH in Q3 2015 and has held it in 29 quarters since. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • D.E. Shaw & Co held 5,107,561 shares of Evolent Health worth $27.7M as of Q2 2026.
  • D.E. Shaw & Co sold 326,471 Evolent Health shares in Q2 2026, an estimated $1.25M.
  • Evolent Health made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1086 holding.
  • D.E. Shaw & Co first reported a position in Evolent Health in Q3 2015 and has held it in 29 quarters since.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.